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Abstract
The Affordable Care Act (ACA) is forecast to increase the demand for and utilization of substance 
use disorder (SUD) treatment. Massachusetts implemented health reforms similar to the ACA in 
2006 -2007 that included expanding coverage for SUD treatment. This study explored the impact 
of Massachusetts health reforms from 2007 to 2010 on SUD treatment providers in Massachusetts, 
who relied on fee-for-service billings for more than 50% of their revenue. The changes across 
treatment facilities located in Massachusetts were compared to changes in other similar fee-for-
service funded SUD treatment providers in Northeast states bordering Massachusetts and in all 
other states across the US. From 2007-2010, the percentage changes for Massachusetts based 
providers were significantly different from the changes among providers located in the rest of the 
US for admissions, outpatient census, average weeks of outpatient treatment, residential/in-patient 
census, detoxification census, length of average inpatient and outpatient stays, and provision of 
medication assisted treatment. Contrary to previous studies of publicly funded treatment providers, 
the results of this exploratory study of providers dependent on fee-for-service revenues were 
consistent with some predictions for the overall effects of the ACA
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The Affordable Care Act (ACA) is forecast to increase the demand for and utilization of 
substance use disorder (SUD) treatment service providers because it will require mental 
health and SUD insurance coverage, apply Federal parity protections for SUD treatment, 
and provide previously uninsured persons with treatment access through private health 
insurance and Medicaid (U.S. Congress 2006; Beronio, et al. 2013). Increased coverage of 
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payment for SUD treatment provided by the ACA may remove significant barriers that may 
currently limit utilization of SUD treatment providers. Based on combined data for 
2007-2010, the National Survey of Drug Use and Health estimated that 32% of those 
perceiving an unmet need for SUD treatment cited lack of health coverage and inability to 
afford the anticipated cost as primary barriers to obtaining available treatment (SAMHSA 
2010). On a national basis, providing insurance coverage to these persons could increase the 
patients utilizing SUD treatment providers by at least 12% (SAMHSA 2011a). The ACA 
may also change the types and characteristics of SUD treatment service providers, since as 
more persons are provided coverage, the portion of total SUD treatment services financed by 
health insurance and Medicaid is likely to increase, while the portion supported by public 
grants decreases (Buck 2011).
Since changes in treatment utilization for SUD would be indicators that the predictions 
about the impact of the ACA are accurate, examining these changes is important. However, 
the implementation of ACA has moved more slowly than might have been expected, and 
there are yet to be reports in the secular media about changes in numbers of people seeking 
treatment. The experience of Massachusetts, which earlier implemented legislation similar 
to the ACA, may suggest national changes in SUD treatment as the ACA becomes fully 
implemented across the nation.
In 2006-2007, Massachusetts expanded the Medicaid system and mandated coverage for 
treatment of substance use and psychiatric disorders, foreshadowing similar provisions of 
the ACA and the Mental Health Parity and Addictions Act of 2008 (Holaha & Blumberg 
2006; SAMHSA 2014). The Massachusetts health reforms created a ‘natural experiment’ 
offering a partial test of predictions for the effects of ACA on SUD treatment providers 
(Long & Stockley 2011)
Previous studies have shown limited effects of Massachusetts health care reform on SUD 
treatment organizations (Capoccia et al. 2012). These works focused on fundamentally 
different sets of SUD treatment providers than those considered in the present study. 
Capoccia and colleagues (2012) examined a sample of large Massachusetts treatment 
providers which derived over 60% of their revenues from state appropriations and block 
grant funds and found that these organizations experienced minimal changes in new 
admissions from 2006-2009. Across this sample, admissions increased by 19% only in 2010. 
Although availability of increased insurance coverage might also increase length of patient 
stay in treatment, the service units delivered within these organizations also remained 
essentially unchanged over the study period (Capoccia et al. 2012). A separate research 
report in 2010 also found that publicly funded facilities in Massachusetts experienced no 
increase in demand for SUD treatment following health reform and suggested that 
Massachusetts’ health reforms would likely benefit fee-for-service funded providers 
(NASADAD 2010).
Officials in Massachusetts also have suggested that newly insured individuals might 
primarily use fee-for-service SUD treatment providers (Stewart & Horgan 2011). Further, 
the 2009-2010 revision of the Massachusetts SUD Strategic Plan predicted that expanded 
coverage might shift patient demand from providers funded by public sector block grants to 
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fee-for-service providers (State of Massachusetts 2010). Other research has also suggested 
that increases in demand for treatment services due to expanded coverage under ACA may 
occur primarily among treatment providers able to efficiently bill for third party 
reimbursement and manage the flexibility and risks inherent to a fee-for-service business 
model (Buck 2011).
These predictions suggest that patterns of admissions and service utilization due to 
Massachusetts reforms may have been different within SUD treatment providers operating 
on fee-for-service revenue, rather than public grant funds. This is the first research question 
of this study. Thus the present study explores the impact of the Massachusetts health reforms 
from their early stages in 2007 through implementation to 2010 in a sample of SUD 
providers who relied on fee-for-service billings to insurance, Medicaid, Medicare, or self-
paying patients for more than 50% of their revenue. The second question is whether the 
reforms affected fee-for-service dependent providers in Massachusetts differently than in 
other locations. To answer this question, changes over 2007- 2010 in Massachusetts fee-for-
service treatment providers were compared to changes over the same period in samples of 
similar fee-for-service based treatment providers located both in northeastern states 
contiguous to Massachusetts, and located across the US.
Many of the projected effects of the ACA and the Massachusetts reforms on SUD treatment 
providers focus on expanded demand for services due to increased resources available to 
patients. Greater resources available to SUD patients may be reflected in higher levels of 
treatment admissions as well as on-going census levels (Buck 2011). Patients with more 
insurance resources may stay in treatment longer, and higher levels of admissions may 
require larger numbers of employees. Thus this study explored changes in the following 
demand and capacity related variables in each group of fee-for-service dependent SUD 
treatment providers: annual admission levels across all types of services; census levels for 
residential/inpatient, outpatient and detoxification services; average length of stay for 
residential/inpatient and outpatient services; and number of employees. If fee-for-service 
dependent treatment providers attract larger numbers of patients, these providers may be 
challenged to maintain high quality and comprehensive care (Ducharme, et al., 2007) which 
includes both core SUD treatment services as well as medically assisted treatment options, 
and wrap-around services covering co-occurring problems such as general medical 
disorders, transportation, legal and other services. As a result, this study also explored 
changes in the following quality of care related variables: provision of combined core and 
wrap-around services; provision of medically assisted treatment; and percentage of 
counselors with masters’ degrees. .
Methods
The National Treatment Center Study (NTCS)
Longitudinal information about the organizations studied was drawn from the National 
Treatment Center Study (NTCS). The NTCS is a national study of organizations that 
provide SUD treatment and which rely on fee-for service funding for more than 50% of their 
revenue. The initial sample for this study was selected using a two-stage stratified process 
where treatment providers were randomly sampled within population strata. Telephone 
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screening was used to establish eligibility for the study. Eligibility focused on treatment 
organizations available in communities. SUD treatment providers included in the NTCS 
must offer SUD treatment at ASAM Level 1 outpatient services or higher and receive more 
than 50% of their annual revenues from fee-for-service billings to third parties including 
health insurance, Medicaid, Medicare, and patient payments. Selection of participant 
organizations excluded counselors in private practice, halfway houses, transitional living 
facilities, methadone maintenance facilities, court-ordered driver education, correctional, 
and VA facilities (Fields & Roman, 2010; Fields, et al., 2012)
Treatment providers participating in the NTCS were visited every 2 years. The data for this 
study were collected during on-site visits and face-to-face interviews in 2007-2008 and 
2009-2010. Data were collected from these treatment providers using interviews of 
administrative and clinical directors conducted on-site. Both directors were provided with 
revenue, census, and treatment services questions in advance of the interviews and asked to 
consult organizational records for these data prior to the site visits. Interview guides and 
informed consent procedures were approved by the University of Georgia Institutional 
Review Board.
Data collected from each provider include measures of internal management practices, 
revenues, patient referral sources, levels of care, and adoption of evidence-based practices 
such as comprehensive care and medication assisted treatment. Empirical investigations of 
organizations are often faced with a lack of archival data about constructs of interest, and 
thus rely on data reported by key informants (Kumar, Stern & Anderson, 1993). Key 
informants have been used in research studies to describe organizational variables including 
innovation adoption, environmental influences, power of major suppliers and customers, 
human resource practices, and quality management practices (Fields, Roman & Blum, 2012; 
Fields & Roman, 2010; Phillips, 1981).
To maintain sample size over the life of the NTCS, replacements for organizations that left 
the sample through closure or other attrition were randomly drawn from updated directories 
of providers. In 2007-2008, 345 fee-for service dependent treatment providers participated 
in the NTCS; in 2009-2010, 329 treatment centers were involved. Since the focus of the 
study was on changes occurring across a group of providers between 2007 and 2010, it was 
necessary that the same providers were present for both time periods (Singer & Willett 
2003). A sample of 274 SUD treatment providers provided NTCS data in both 2007 and 
2010 was available for analysis, representing retention of 79% across the two data collection 
periods. Massachusetts sample
Nine SUD treatment providers located in Massachusetts provided NTCS data in 2007 and 
2010 and these providers form the study sample. In order to assess the extent to which the 
study sample is representative of all SUD treatment providers in Massachusetts Table 1 
compares the study sample of Massachusetts SUD treatment providers with 307 
Massachusetts treatment organizations that responded to the National Survey of Substance 
Abuse Treatment Services (N-SSATS) in 2010.
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As this table shows, the providers in the study sample were similar to Massachusetts N-
SSATS-2010 respondents in for-profit/non-profit status, and in size distribution. However, 
organizations in the study sample were larger on average and more likely to offer outpatient, 
residential/inpatient, and detox services than overall N-SSATS-2010 Massachusetts 
respondents. Further, providers in the Massachusetts sample received 50% or more of 
revenues from fee-for service billings while Massachusetts N-SSATS participants may have 
received larger percentages of revenue from public funds. (N-SSATS 2010 state level data 
does not provide the SUD treatment provider percentage of revenue by source). The N-
SSATS data at the state level are also aggregated across all participating survey respondents. 
In 2010, Massachusetts N-SSATS respondents included 4 providers operated by the 
Department of Veterans Affairs and 1 operated by the department of Defense. Federally 
operated SUD treatment provides were excluded from the NTCS sampling frame. Inclusion 
of the federally operated treatment providers may have unknown impact in the comparison 
of the Massachusetts study sample with the Massachusetts N-SSATS respondents shown in 
Table 1.
Comparison samples
The NTCS comparison sample for Northeastern states contained 32 SUD treatment 
providers who provided NTCS data in both 2007 and 2010 and that were located in the 
states of New York, New Hampshire, Vermont, Maine, and Connecticut. These NTCS 
participants also received 50% or more of their revenues from fee-for-service billing. These 
states also had comparable levels of SUD admissions per 100,000 residents to Massachusetts 
over the same time period (SAMHSA 2011b). The SUD treatment providers in the 
Massachusetts study sample were somewhat larger (mean = 77 employees) than the SUD 
treatment providers in the NTCS participants in the Northeast comparison sample (mean = 
53 employees). The Massachusetts SUD treatment providers in the study sample obtained 
92% of revenue fee-for-service, a larger percentage than the Northeast comparison sample 
SUD treatment providers (79% on average)
The comparison sample for all of the US outside Massachusetts contained 265 SUD 
treatment providers who provided NTCS data in both 2007 and 2010. These NTCS 
participants also received 50% or more of their revenues from fee-for-service billing. The 
SUD treatment providers in the Massachusetts study sample were somewhat larger (mean = 
77 employees) than the SUD treatment providers in the NTCS participants in the 
comparison sample for the rest of the US (mean = 39 employees).
The Massachusetts treatment centers obtained 92% of revenue fee-for-service, a larger 
percentage than fee-for-service dependent SUD treatment providers in the rest of the US 
(82% on average). Neither of these measures (mean employees and percent fee-for-service 
revenue) was significantly different from those in the comparison samples of SUD treatment 
providers in the Northeast and US.
Measures
Annual admissions—These are total admission to all forms of treatment offered by the 
SUD treatment provider in the past year. In order to capture the changes in the treatment 
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system over 2007-2010, the aggregate admissions were summed across the Massachusetts 
sample and across the comparison samples.
Residential/Inpatient census—Clinical directors were asked to provide the current 
patient census for each of inpatient SUD treatment (less than 30 days in residence), 
residential SUD treatment (greater than 30 days) and inpatient psychiatric services. The 
summed values was used as a point estimate of the treatment center census for residential/
inpatient services. The aggregate residential/inpatient census was summed across the 
Massachusetts and comparison samples.
Outpatient census—Clinical directors provided current patient census levels for partial 
hospitalization (day treatment), intensive outpatient, and traditional outpatient. These values 
were summed as a point estimate of the treatment center outpatient census. The aggregate 
outpatient census was summed across the Massachusetts and comparison samples.
Detox census—Clinical directors of each treatment center also provided current patient 
census for inpatient and outpatient detox services. These were summed to form the detox 
census for each center. The aggregate census was summed across the Massachusetts and 
comparison samples.
Average inpatient length of stay—Clinical directors were asked to provide the average 
length of stay in days for each of type of residential/inpatient treatment. These values were 
averaged for each treatment center to estimate the average inpatient length of stay measures 
in days. The values for treatment centers were then averaged across centers in the 
Massachusetts and comparison samples.
Average outpatient length of stay—Clinical directors provided the average patient 
length of stay in weeks for each type of outpatient treatment. These values were averaged 
for each treatment center to estimate the average outpatient length of stay. The values for 
treatment centers were then averaged across centers in the Massachusetts and comparison 
samples.
Comprehensive care index—Following Ducharme and colleagues (2007) the extent of 
comprehensive care used an index of core and ancillary services. This index summed 
indicators of use of the ASI at intake/assessment; patient random drug testing; one or more 
12-step groups; use of buprenorphine, naltrexone, methadone, disulfiram, or SSRIs, 
aftercare/continuing care; childcare; transportation assistance; treatment for HIV/AIDS 
patients; integrated care for dual diagnosis patients; and links with primary medical care; 
employment services; financial aid; family counseling; and legal services. The index values 
for treatment centers were averaged across centers in each sample.
Percentage providing medication assisted treatment—Clinical directors indicated 
if their treatment center prescribes or dispenses any medications for SUD treatment. The 
responses were coded 1 if yes and 0 if no. The percentage in each sub-sample offering this 
treatment approach was calculated.
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Percentage of counselors with masters degrees—Administrative directors 
provided the number of SUD counselors with masters’ degrees working in each center. This 
number was divided by the total number of counselors to obtain the percentage.
Total employees—Administrative directors were asked for the total number of employees 
working in each organization (full-time and part –time, both clinical and non-clinical). 
These totals were summed across all organization in the Massachusetts and both comparison 
samples.
Analytic Plan
To explore impacts of Massachusetts health reforms on the fee-for-service funded system of 
providers, this study investigated changes in measures aggregated across the organizations 
within each sub-sample in each time period. That is, the research question is directed at 
estimating the effects of health reform on fee-for-service dependent SUD providers within 
each of the geographic areas (Massachusetts, contiguous northeastern states, and the rest of 
the US). This approach does not claim that the individual centers in the subsample are 
representative of all fee-for-service dependent providers in Massachusetts, the contiguous 
Northeastern states, or the rest of the US. The sum of the values within each sub-sample is 
used as a point estimate of the population value (Wallace & Silver 1988). This approach 
treats the changes in aggregated values of each of the study variables across centers in each 
sub-sample as estimates of the changes occurring within fee-for-service treatment provider 
system in each geographic area. This follows the approach taken in previous studies of 
Massachusetts health reforms (Capoccia, et al. 2012). Since this study focuses on differences 
in the changes over time between the geographic sub-samples, the extent and direction of 
percentage changes in key treatment system variables were assessed for statistical 
significance using t-tests (Nunnally 1959)
Results
Massachusetts-based SUD treatment providers primarily funded by fee-for service revenues 
had substantially increased admissions from 2007-2010. These treatment organizations also 
increased the number of outpatients in treatment, and the average weeks that these patients 
stayed in treatment. Both changes are consistent with patients using increased access to 
insurance coverage to enter and remain in treatment. However the Massachusetts treatment 
organizations had reduced residential/in-patient and detoxification census levels and these 
patients averaged shorter stays. Within this group of Massachusetts providers, total 
employees were reduced by 18%. These changes are described in the left-hand portion of 
Table 2.
Compared to treatment providers in adjoining states, Massachusetts facilities had larger 
changes in admissions, increases in outpatient census, decreases in average length of 
residential/inpatient stay, decreases in detox patients. In addition, the Massachusetts 
providers decreased the number of employees, while similarly funded organizations in the 
Northeast increased.
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The patterns of changes in Massachusetts based treatment providers from 2006 -2010 are 
compared to the sample of similarly fee-for–service funded treatment centers located in the 
rest of the US in Table 3. Admissions increased in the Massachusetts centers, but declined in 
similarly funded organizations in other states; outpatient census and average length of stay 
both increased in the Massachusetts sample, but outpatient census decreased while length of 
stay in treatment remained essentially constant in other states. Finally, the detoxification 
census in the Massachusetts centers declined by 11%, but increased by 89% in treatment 
centers located elsewhere.
There were no significant differences between Massachusetts treatment providers and those 
in the Northeast or the rest of the US in the changes in two indicators. These were the extent 
to which a center provides comprehensive care (basic SUD treatment essentials as well as 
wrap-around services) and percentage of counselors with masters’ level education. Two 
other indicators of treatment quality increased significantly more in Massachusetts providers 
than in treatment centers in other states. These were provision of medication assisted 
treatment and average outpatient length of stay.
Discussion
The patterns of changes following implementation of health care reforms for Massachusetts 
treatment organizations which derive most of their income from fee-for-service funding are 
consistent with the effects forecasted for ACA. Specifically, across our sample of fee-for-
service treatment organizations in Massachusetts, patient admissions outpatient census, 
average outpatient weeks of stay in treatment, and provision of medication assisted 
treatment increased significantly more than across a sample of SUD treatment providers 
located across the US. At the same time, residential/inpatient census and average length of 
stay, as well as detox census decreased across the Massachusetts providers and these 
changes differed significantly from the changes for treatment providers across the country. 
The changes across Massachusetts providers also differed significantly from change patterns 
within treatment providers reliant on fee-for-service funding located within the Northeast 
US. The northeast sample include SUD treatment providers located in Vermont and Maine, 
states which implemented more limited forms of health care reforms than Massachusetts..
These differences in changes between Massachusetts and the sample of SUD treatment 
centers across the US are consistent with changes forecasted due to the ACA (Buck 2011). 
These forecasts predict that health care reform Medicaid expansion and parity requirements 
will result in greater aggregate demand for SUD treatment since more prospective patients 
would now have means of payment. They also suggest a shift away from residential 
treatment (which is not often covered by Medicaid plans or health insurance) and increased 
emphasis on medically-assisted treatment. The changes in the samples of treatment 
organizations studies here also differed from previously reported patterns over the same time 
period in a set of publicly funded treatment SUD treatment providers within Massachusetts 
(Capoccia et al. 2012)
Although these analyses were explored in samples that may not be representative of all fee-
for-service revenue based providers in each location, the differences observed tend to 
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support the perspective that health care reform may have greatest impact on those SUD 
treatment providers whose business model is based on billing third parties for 
reimbursement. Expanded insurance coverage may not only increase admissions at these 
facilities, but also enable persons already in treatment to remain for longer periods, a 
positive implication as longer engagement in outpatient treatment is associated with better 
treatment outcomes. It is notable that from 2007-2010, two indicators of treatment quality 
(average outpatient length of stay and provider offering medication assisted treatment) had 
larger positive changes in the Massachusetts sample compared the centers located across the 
US. The changes in two other indicators of quality (provision of comprehensive care and 
percentage of counselors with masters’ level education) were not different across the 
Massachusetts centers compared to SUD treatment providers located across the country. 
However, the negative percentage change in employees within the Massachusetts centers 
was significantly different from the positive change in employees across the sample of SUD 
treatment providers across both the Northeast and US as a whole. The decrease in overall 
SUD treatment staff across the Massachusetts providers does bring into question the stability 
of these quality indicators.
These results suggest that health care reform policies and funding incentives resulted in 
changes in the types of SUD treatment handled by different types of providers. For example, 
a goal of the Massachusetts Strategic Plan for Substance Abuse was a shift from inpatient 
episodes of care to outpatient settings at treatment centers (State of Massachusetts 2010). 
Across the fee-for-service Massachusetts providers in this study, residential/inpatient census 
and average length of stay decreased. In addition, although Medicaid expenditures for detox 
services increased within Massachusetts as a whole from 2007-2010, the detox census in the 
study sample decreased over the same period (Capoccia et al. 2012). These changes are 
consistent with previous research suggesting that health reforms shifted SUD treatment 
emphases from acute-care to a recovery-oriented system-of-care model focused more on 
outpatient care.
Some of these changes may also reflect effects of Massachusetts’ 2008 implementation of a 
managed care system in conjunction with health reforms. Managed care covering SUD 
treatment may have imposed treatment guidelines and incentives for use of lower-cost 
treatment methods, creating pressures that shifted more acute cases requiring inpatient care 
to public sector supported treatment centers (Long & Stockley 2011). Treatment providers 
that are heavily reliant on reimbursement sources may be very responsive to policies and 
procedures that affect third party payments and fine-tune treatment practices accordingly.
While our data do not have the precision to measure the various factors that might have 
contributed to the decline in the organizational workforces among the treatment providers 
we examined, it appears logical that the reduced delivery in these centers of both detox and 
residential services effected the management decisions to make staff reductions. This 
highlights the possibly greater economic sensitivity to patient flow in centers primarily 
dependent on fee for service revenues as compared to those benefiting from public revenues. 
Whether detox and residential patients were shifted to the public sector is beyond the scope 
of our data, but the small changes in caseload revealed in the publicly funded organizations 
studied by Capoccia and his colleagues do not offer strong support to this possibility.
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Study limitations
The sample of fee-for-service funded SUD treatment providers in Massachusetts is small, 
comprising 3% of the 307 SUD treatment providers in Massachusetts. While this small 
sample is similar in type of ownership and size distribution to the N-SATSS 2010 inventory 
of Massachusetts facilities, it may differ in other unmeasured ways. These unmeasured 
variables could account for the changes in the Massachusetts study sample as well as the 
differences in changes between the study sample and other comparable treatment providers 
in the northeast and the rest of the US. Although healthcare reforms including increased 
coverage for SUD treatment were implemented in Massachusetts in 2006, we do not have 
information about the familiarity of the sampled treatment providers with reforms, the extent 
to which these facilities helped prospective patients obtain coverage, or the extent of 
premium costs or co-pay requirements faced by SUD patients. Data about the sources of 
revenue, census levels, staffing, and the dependence on fee-for-service billings were 
provided by administrative directors acting as key informants. While these directors were 
provided with these questions in advance and asked to consult organizational records, it is 
possible that these key informants did not have completely accurate data. The sources of 
revenue, census levels, or utilization levels were not verified with insurance claims data or 
other publicly available information about the SUD treatment providers. While the 
comparison of the changes in Massachusetts providers with similar providers located 
elsewhere helped control for effects of other trends, the small sample size limited the ability 
to isolate such other effects through techniques such as multivariate regression.
Conclusions
Overall, our results support the forecast that the ACA, Medicaid expansion, and increased 
coverage requirements may contribute to increased admissions and services provided by 
SUD treatment providers who focus on reimbursements from health insurance, self-paying 
clients, and Medicaid/Medicare. The results suggest also that these centers may shift 
treatment emphasis in response to reimbursement policies and priorities. In general, 
providers which are more reliant on income from third party billings may be responsive to 
policy driven changes in revenue opportunities while working within the challenge of 
managed-care environments. However, the treatment system overall may need further 
support and incentives for expansion, since Massachusetts rates of unmet treatment need 
from 2002-2010 showed no significant decline (Zhu et al. 2010).
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